戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cts with oxygen related to the efficiency of photosensitizing.
2 xo chain secondary building units (SBUs) and photosensitizing 5,10,15,20-tetra( p-benzoato)porphyrin
3 dinuclear W(VI) secondary building units and photosensitizing 5,10,15,20-tetra(p-benzoato)porphyrin (
4               The dual tension reporting and photosensitizing abilities of Flipper enable simultaneou
5                                  The in vivo photosensitizing ability of melanin is unknown.
6                                  The triplet photosensitizing ability of preoxidized DOM was determin
7 he various approaches for the improvement of photosensitizing activity and the enhancement of catalyt
8 lasmids, is examined as a potential cellular photosensitizing agent and offers unique opportunities a
9 ew treatment modality, uses a combination of photosensitizing agent and visible light for the therapy
10 ophobic PSs to a cationic peptide produces a photosensitizing agent effective against Gram-negative b
11 This paper describes the accumulation of the photosensitizing agent protoporphyrin IX in areas of pla
12 The application of laser treatment without a photosensitizing agent proved effective in controlling c
13  therapy (PDT), cells are impregnated with a photosensitizing agent that is activated by light irradi
14  (PDT), using aluminum phthalocyanine as the photosensitizing agent.
15 ommended for adequate penetration of topical photosensitizing agents and subsequent protoporphyrin IX
16 sis on biological evaluation of FDA approved photosensitizing agents as well as newly designed nanoph
17 mpounds of vegetable origin that are used as photosensitizing agents in the treatment of various skin
18  enhancing intracellular accumulation of the photosensitizing agents used in this study, we propose t
19 braries of potential chemical and biological photosensitizing agents.
20 igations of molecular tweezers incorporating photosensitizing anthracene units and a central terpyrid
21 oximately 30 nm), entrapping water-insoluble photosensitizing anticancer drug 2-devinyl-2-(1-hexyloxy
22 ith BCC, and especially early-onset BCC, and photosensitizing antimicrobials.
23     COFs with long-range pai-conjugation and photosensitizing building blocks have been explored for
24 ic performance than T due to the presence of photosensitizing C(70).
25                                 To probe the photosensitizing capabilities of the C-Dots, we followed
26                            The extraordinary photosensitizing capacity of Ru-3T and Ru-4T may stem fr
27 ew modality that utilizes a combination of a photosensitizing chemical and visible light for the mana
28 er treatment that employs a combination of a photosensitizing chemical and visible light, induces apo
29 is a bimodal therapy using a porphyrin based photosensitizing chemical and visible light.
30 us demonstrating selective destruction of HS photosensitizing chromophores.
31 kin cancer, involves the administration of a photosensitizing compound followed by illumination of th
32                                        These photosensitizing compounds absorb light energy which ena
33 dicate the pool of fluorescent compounds and photosensitizing compounds in SRFA are likely distinct f
34 ilamentous Cercospora fungi are resistant to photosensitizing compounds that generate singlet oxygen.
35 rapy (PDT) depends upon the delivery of both photosensitizing drug and oxygen.
36                           Irradiation of the photosensitizing drug entrapped in nanoparticles with li
37                 Photochemotherapy-in which a photosensitizing drug is combined with ultraviolet or vi
38 (a) the localization in the target site of a photosensitizing drug; and (b) the activation of the pho
39 ar degeneration, using laser activation of a photosensitizing dye to achieve closure of choroidal neo
40 amic therapy is the combination of non-toxic photosensitizing dyes with harmless visible light that t
41 ores the importance of these products in the photosensitizing effect of BrdU.
42 he cage structure significantly promotes the photosensitizing effect of porSMNs by inhibiting the pai
43 yrimidines in duplex DNA may account for the photosensitizing effects of these nucleosides.
44 s (R- and S-isomers) showed similar in vitro photosensitizing efficacy and limited skin phototoxicity
45 -4)-Glc) produced a considerable increase in photosensitizing efficacy in vitro.
46 relation between 17 displacement ability and photosensitizing efficacy of photosensitizers was observ
47                                          The photosensitizing efficacy of the monomers and the relate
48                      The preliminary in vivo photosensitizing efficacy of this stable bacteriopurpuri
49 tion between the binding constant values and photosensitizing efficacy was observed.
50 stituted-imide ring system produced enhanced photosensitizing efficacy with limited skin phototoxicit
51 ectroscopic properties, preliminary in vitro photosensitizing efficacy, and tumor selectivity were de
52 esis, photophysical characteristics, in vivo photosensitizing efficacy, human serum albumin (HSA) bin
53 osition-132) of the molecule showed enhanced photosensitizing efficacy.
54 fluoromethyl)benzylamine, produced promising photosensitizing efficacy.
55 d lactose) produced a 100% decrease in their photosensitizing efficacy.
56 conjugate did not show any inhibition in its photosensitizing efficacy.
57 arbon-carbon linked dimers produced enhanced photosensitizing efficacy.
58 /cm2, all benzochlorins produced significant photosensitizing efficacy.
59 nding site (albumin site II) and the in vivo photosensitizing efficacy.
60 d Hf(12) secondary building units (SBUs) and photosensitizing Ir(DBB)[dF(CF(3))ppy](2)(+) [DBB-Ir-F,
61 oscale metal-organic frameworks (nMOFs) with photosensitizing ligands can enhance radiation damage to
62 othermal synthesis between HfCl(4) and three photosensitizing ligands followed by postsynthetic modif
63                      Efficient heterogeneous photosensitizing materials require both large accessible
64 to investigate possible associations between photosensitizing medication use and NMSC.
65 examine the association between a history of photosensitizing medication use and non-melanoma skin ca
66 ge) (OR=1.5, 95% CI=1.1-2.1) associated with photosensitizing medication use.
67   In conclusion, certain commonly prescribed photosensitizing medications may enhance the risk of dev
68  the concomitant loss of chromophores (i.e., photosensitizing moieties).
69 moieties had larger effects than the loss of photosensitizing moieties.
70 clined, mainly reflecting the destruction of photosensitizing moieties.
71  encoded proteins that form or bind a native photosensitizing molecule, resulting in a constitutively
72                      Harnessing sunlight via photosensitizing molecules is key for novel optical appl
73 isting of plasmonic silver nanoparticles and photosensitizing molecules, where strong resonance coupl
74                          Herein, we report a photosensitizing nanoscale metal-organic layer (MOL) wit
75 losporine and azathioprine may contribute as photosensitizing or DNA damaging agents.
76 gates as an energy up-converting donor and a photosensitizing PDT drug as an acceptor.
77 euronal nAChRs and open a general pathway to photosensitizing pentameric ligand-gated ion channels.
78    Recently, photocatalytic systems based on photosensitizing perylene monomimide (PMI) chromophore a
79 composed of a DNA-binding PS (Br-DAPI) and a photosensitizing photocage (WinterGreen).
80                   Endogenous aBL-activatable photosensitizing porphyrins in N. gonorrhoeae were ident
81                                        Their photosensitizing potential for photodynamic therapy was
82                 The singlet oxygen ((1)O(2)) photosensitizing propensity of some phenalenones was inv
83                                 Although the photosensitizing properties of estrogens have been recog
84 t further motivates to explore the potential photosensitizing properties of small alkyl-substituted i
85 y of the resultant complexes to modulate the photosensitizing properties of the drug.
86                       The photochemistry and photosensitizing properties of the kinds of biogenically
87  density functional theory) established good photosensitizing properties of the metalloporphyrins.
88 urther explores the correlations between the photosensitizing properties of WWOM and optical characte
89 ts of DOM preoxidation on the inhibiting and photosensitizing properties were assessed by phototransf
90 ntaining BODIPY chromophores having tuneable photosensitizing properties.
91 ical activities, coordination behaviors, and photosensitizing properties.
92            Cell-specific genetically encoded photosensitizing proteins, such as KillerRed, permit spa
93                             Development of a photosensitizing system that can reversibly control the
94 eme is selective toward molecules capable of photosensitizing the formation of singlet molecular oxyg